Beyond the cage: The rise and promise of non-animal models in biomedical research

The accelerating shift in biomedical research toward human-relevant, ethical, and innovative methodologies has propelled the adoption of Non-animal models (NAMs) as vital alternatives to traditional animal models. This review examines the different types of NAMs, including in vitro models such as 2D cell cultures, organoids, spheroids, organs-on-a-chip, and advanced in silico tools such as artificial intelligence (AI)-driven models, molecular docking, Physiologically Based Pharmacokinetic (PBPK) models, and Quantitative Structure-Activity Relationship (QSAR) approaches, in the context of their capacity to replace, reduce, and refine animal use. Drawing on historical and contemporary applications, we analyze the experimental utility, translational value, and limitations of each NAM against the benchmark of well-established animal models, emphasizing the ability of NAMs to capture human physiology, enhance throughput, and address ethical imperatives. Despite significant progress, NAMs face challenges in recapitulating systemic complexity and regulatory standardization. The review identifies current technological gaps and articulates future directions, with particular emphasis on multi-organ platforms, computational innovations, and data harmonization. Ultimately, continual advances in NAMs, coupled with evolving regulatory frameworks and ethical considerations, are redefining the standards and trajectory of preclinical biomedical research, paving the way toward safer, more predictive, and humane scientific practices.